SCHEMBL4734764

SCHEMBL4734764

CCCc1ccnc(C(=O)C=CN(C)C)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.57
ALDH1A1 P00352 7/20 0.57
RAB9A P51151 6/20 0.57
NPC1 O15118 4/20 0.57
KMT2A Q03164 1/20 0.57
HTT P42858 5/20 0.44
RECQL P46063 2/20 0.43
GAA P10253 3/20 0.42
HPGD P15428 2/20 0.40
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
ALOX12 P18054 1/20 0.38
LATS1 O95835 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
SMYD3 Q9H7B4 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4735152 0.89 HTT (0.46) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL14651335 0.82 MAPT (0.44) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL12501401 0.82 MAPT (0.44) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL4736636 0.78 HTT (0.50) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL7239456 0.78 HTT (0.50) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL24369170 0.77 ALDH1A1 (0.53) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL14651339 0.77 MAPT (0.59) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL29488881 0.77 MAPT (0.59) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL14651291 0.77 MAPT (0.59) MAPTALDH1A1RAB9ANPC1KMT2A
SCHEMBL12501384 0.77 MAPT (0.59) MAPTALDH1A1RAB9ANPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466154-B2 Methods and compositions related to wrapping of dehydrons THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-06-18 US disclosed
US-20130131076-A1 METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-05-23 US disclosed
WO-2008070350-A9 METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS UNIV TEXAS (US) 2008-10-23 WO disclosed
WO-2008070350-A2 METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2008-06-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131076-A1 METHODS AND COMPOSITIONS RELATED TO WRAPPING OF DEHYDRONS DKK1, HPN, OSBP2 MAPT 3980/4885ALDH1A1 3889/4885RAB9A 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.